Skip to main content

Table 1 Classification of xenograft tumors based on TNBC subtypes

From: Patient-derived xenografts of triple-negative breast cancer reproduce molecular features of patient tumors and respond to mTOR inhibition

Xenograft ID

TNBC subtype

SUTI097

immunomodulatory (IM)

SUTI103

basal-like 1 (BL1)

SUTI110

basal-like 1 (BL1)

SUTI151

basal-like 2 (BL2)

SUTI151M

mesenchymal (M)

SUTI319

unstable (UNS)

SUTI368

unstable (UNS)

  1. TNBC, Triple-negative breast cancer.